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Abstract
Naturally existing vitamin K consists of vitamins K1 and K2. Menaquinone‐4 (MK‐4),
an analog of vitamin K2 and a product of vitamin K1 metabolism, can be detected in
several organs, including the testis; however, the function of MK‐4 in these tissues has
not been well characterized. Recent studies have suggested that vitamin K is involved
in enhancing protein kinase A (PKA) activity in several cell  types, thus regulating
numerous PKA‐dependent biological processes. To highlight the effect of vitamin K, we
focused on its role in the steroidogenic pathway. Experiments on vitamin K–deficient
rats revealed a reduced expression of genes involved in the biosynthesis of cholesterol
and steroid hormones in the testis. Moreover, compared with control animals, rats fed
on MK‐4 diet presented significantly higher testosterone levels in the plasma and testis.
These results suggest that vitamin K is involved in the steroidogenic pathway in the
testis. Testosterone levels were found to increase in a dose‐dependent manner also in
cell‐based experiments upon addition of MK‐4, but such an effect was not observed in
vitamin K1 levels. Furthermore, the effect of MK‐4 on testosterone production was
abolished by the specific PKA inhibitor H89, thus confirming the regulatory role of MK‐
4  on PKA activation.  Here,  we describe  how MK‐4 modulates  PKA activation by
enhancing intracellular 3′,5′‐cyclic adenosine monophosphate (cAMP) levels in testis‐
derived I‐10 cells. The presented evidence supports the role of MK‐4 in cAMP/PKA
signaling and steroidogenesis.
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1. Introduction
Naturally existing vitamin K comprises vitamin K1 (phylloquinone) and vitamin K2 (mena‐
quinone). Menaquinone‐4 (MK‐4), an analog of vitamin K2, contains a 2‐methyl‐1,4‐naphtho‐
© 2017 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
© 2017 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
quinone ring and a geranylgeranyl group (four isoprene units) as a side chain (Figure 1). MK‐
4 is not commonly synthesized by bacteria and is instead alkylated from menadione, which is
supplemented in animal feeds to increase vitamin K levels. In most organs, MK‐4 is converted
from dietary vitamin K1 and other menaquinones [1, 2] via a process catalyzed by UbiA
prenyltransferase domain containing protein 1 [3].  Furthermore, MK‐4 is prescribed as a
therapeutic agent for osteoporosis and to prevent fractures in Japan [4].
Figure 1. Chemical structure of MK‐4. MK‐4 has a 2‐methyl‐1,4‐naphthoquinone ring and a geranylgeranyl group (four
isoprene units) as a side chain.
Vitamin K is a well‐known nutrient required for blood coagulation and bone metabolism. In
recent years, novel functions of vitamin K against inflammation [5, 6], tumors [7–9], and ligand
of the nuclear receptor PXR (also known as SXR) [10, 11] have been reported. These findings
suggest the beneficial role of vitamin K, including MK‐4, in several biological processes. In
rodents, MK‐4 is distributed throughout the body and is observed in high quantity in the liver,
bone, brain, pancreas, and reproductive organs, even when animals are fed a low MK‐4 diet
(Figure 2) [12–15]. However, the role of MK‐4 in these organs has not been well characterized.
This chapter focuses on the functional effects of MK‐4 on steroidogenesis in testicular Ley‐
dig cells.
Figure 2. Vitamin K contents in rat tissues. Male Wistar rats were fed an AIN‐93G diet for three weeks. Tissue levels of
vitamin K and MK‐4 were determined by fluorescent HPLC (reproduced with permission from Shirakawa et al. [14]).
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2. Steroidogenesis in testicular Leydig cells
The major function of testicular Leydig cells is to produce testosterone in response to the
pituitary luteinizing hormone (LH) as shown in Figure 3. The LH receptor (LHR) affects the
3′,5′‐cyclic adenosine monophosphate (cAMP)/protein kinase A (PKA) signaling pathway by
associating with G proteins containing the cytoplasmic Gαs subunit. Production and secretion
of testosterone in Leydig cells are tightly regulated by intracellular cAMP, a common secondary
messenger. The formation and degradation of intracellular cAMP are under the control of
adenylate cyclase (AC) and cyclic nucleotide phosphodiesterase (PDE), respectively. A rise in
intracellular cAMP levels activates PKA, which stimulates downstream steroidogenic proteins.
Steroidogenic acute regulatory (StAR) protein transports cholesterol to the inner mitochon‐
drial membrane of these cells to initiate steroidogenesis. Cytochrome P450scc (also known as
CYP11A), a cholesterol side‐chain cleavage enzyme, catalyzes a cascade of reactions that
convert cholesterol to the steroid hormone precursor pregnenolone, which is then transformed
into testosterone [16]. Both StAR and CYP11A constitute rate‐limiting steps in the overall
steroidogenesis of testosterone from cholesterol.
Figure 3. Steroidogenic pathway in testicular Leydig cells. AC, adenylate cyclase; CREB, cAMP response element‐bind‐
ing protein; CYP11A, cholesterol side‐chain cleavage enzyme; G, G protein; HSD, hydroxysteroid dehydrogenase; LH,
luteinizing hormone; LHR, LH receptor; Mito, mitochondria; PDE, cyclic nucleotide phosphodiesterase; PKA, protein
kinase A; SER, smooth endoplasmic reticulum; StAR, steroidogenic acute regulatory protein.
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Testosterone production in men is crucial for fetal development, sperm production, and the
development of male secondary sex characteristics. Furthermore, increasing evidence shows
that lowering testosterone production causes infertility and sexual dysfunction in men,
including cases of late‐onset hypogonadism (LOH) [17, 18]. The current progressive aging of
the population and the stress of modern life may also contribute to LOH, resulting in sexual
dysfunction, muscle weakness, and even depression. Moreover, low testosterone levels can
also predict the development of several diseases, such as type 2 diabetes and cardiovascular
disease [19–21]. This issue could be addressed by identifying nutrients that may boost
testosterone levels.
3. Vitamin K modulates the activation of PKA in various cell types
Vitamin K has been shown to affect several biological processes by modulating the activity of
PKA in different cell lines. Thus, vitamin K has been reported to enhance nerve growth factor‐
mediated neurite outgrowth via PKA activation in PC12D pheochromocytoma cells [22].
Vitamin K2 has also been reported to inhibit growth and invasion of hepatocellular carcinoma
cells through the activation of PKA, which modulates the activities of several transcriptional
factors and inhibits the small GTPase Rho [23]. Furthermore, vitamin K2 has been shown to
modulate gene expression in osteoblasts upon activation of PKA [24]. Taken together, these
findings indicate that vitamin K plays an important role in the activation of PKA in various
cell types.
4. MK‐4 enhances steroidogenesis by activating PKA
We confirmed the link between vitamin K and steroid production using DNA microarray
analysis. We observed that the expression of genes involved in the biosynthesis of cholesterol
and steroid hormones was decreased in vitamin K–deficient rats. The mRNA level of Cyp11a
positively correlated with MK‐4 concentration in the testis. Moreover, testosterone levels in
the plasma and testis of vitamin K–deficient rats were significantly reduced, in spite of normal
levels of plasma LH [25]. Another study further described the effects of dietary vitamin K on
testosterone production. Rats fed on MK‐4‐supplemented diet for five weeks presented
significantly higher plasma and testis testosterone levels compared to those of control rats,
irrespective of changes in plasma LH levels [26]. Moreover, Cyp11a protein levels in the testis
were higher in the MK‐4‐supplemented group than in the control. These results suggest that
vitamin K is involved in steroid production in the testis. To link these results with the anti‐
inflammatory properties of vitamin K observed in the lipopolysaccharide (LPS)‐induced
models [5, 6], we examined the effects of dietary vitamin K on steroidogenesis in LPS‐
induced rats [27]. We found that dietary vitamin K intake affected testicular vitamin K
concentration and offset the LPS‐induced lowering of testosterone synthesis in the testis. In
summary, testicular vitamin K plays an important role in steroidogenesis in Leydig cells.
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We also found a relationship between vitamin K and steroidogenesis in testis‐derived tumor
cells. After incubation of two testis‐derived cell lines, mouse I‐10, and rat R2C, in the presence
of MK‐4, we detected a dose‐dependent rise in secreted testosterone in culture medium [26].
In I‐10 cells, MK‐4, but not vitamin K1, led to increased levels of testosterone. We also found
that menaquinone‐3 and menaquinone‐7 stimulated testosterone production in I‐10 cells
(unpublished data). These results suggest that menaquinones, which have an unsaturated
isoprenyl side chain, enhance testosterone production. In I‐10 cells, the production of proges‐
terone, a testosterone precursor, increased in a dose‐dependent manner following treatment
with MK‐4. This indicates that stimulation of steroidogenesis by MK‐4 occurs upstream of
progesterone synthesis (Figure 2). To assess the effects of MK‐4 on the activation of PKA in I‐
10 cells, a reporter gene assay was employed (Figure 4). The cAMP response element‐driven
luciferase reporter plasmid was transfected into I‐10 cells. Accordingly, MK‐4 enhanced
reporter activity relative to the control. Moreover, Western blot analysis revealed that MK‐4
increased the expressions of Cyp11a, as well as phosphorylation levels of PKA and the cAMP
response element‐binding protein (CREB) in I‐10 cells. In contrast, the increase in testosterone
level induced by MK‐4 was completely abolished by treatment with the PKA inhibitor H89
[26]. These results indicate that, unlike vitamin K1, MK‐4 significantly stimulates testosterone
production and may play an important role in steroidogenesis.
Figure 4. PKA activation following treatment with MK‐4 in I‐10 cells. I‐10 cells were transfected with a plasmid bearing
a cAMP response element fused to a luciferase reporter gene and then treated with MK‐4.
Our findings were in accordance with previous studies by Ichikawa et al. [24], who showed
that MK‐4, but not vitamin K1 or other vitamin K2 isoform, specifically induced mRNA levels
of GDF15 and STC2, whose protein levels are regulated by PKA in human and mouse
osteoblasts. However, Tsang and Kamei have reported that both vitamin K1 and MK‐4 promote
nerve growth factor‐dependent outgrowth of neuronal cells, which were blocked in the
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presence of a PKA inhibitor [22]. The inconsistencies between these studies may be explained
by differences in the uptake, metabolism, and solubility of each vitamin K analog used. In one
example, MK‐4 was taken up faster than vitamin K1 by MG‐63 osteosarcoma cells and HepG2
hepatoma cells by using stable isotope‐labeled vitamin K1 and MK‐4 [28].
In contrast to a report that MK‐4 activated PKA without increasing intracellular levels of cAMP
in hepatocellular carcinoma cells [23], we showed that intracellular cAMP levels increased in
a dose‐dependent manner by treatment with MK‐4 for 1.5 h in I‐10 cells (Figure 5). These results
indicated that MK‐4 enhances testosterone and progesterone production via activation of PKA
as well as modulation of cAMP levels in testis cells.
Figure 5. Intracellular cAMP levels in I‐10 cells upon MK‐4 treatment.
5. The MK‐4 structurally related compound, geranylgeraniol
The C20 isoprenoid compound, geranylgeraniol (GGOH, Figure 6), is a functional side‐chain
component (the geranylgeranyl group) of MK‐4 and has been shown to have a similar
biological function as MK‐4. In addition, GGOH may also have anti‐tumorigenic effects against
prostate cancer [29], colon cancer [30], leukemia [31], as well as anti‐inflammatory activity in
rats [32]. Our latest study revealed a time‐ and dose‐dependent increase in testosterone and
progesterone production in GGOH‐treated I‐10 cells. As expected, addition of GGOH stimu‐
lated also the PKA signaling pathway and augmented intracellular cAMP levels in I‐10 cells
[33].
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Figure 6. Chemical structures of isoprenoid groups; geranylgeraniol (GGOH), geraniol (GOH), farnesol (FOH), phytol
(POH), and geranylgeranyl diphosphate (GGPP).
To further investigate the role of isoprenoids in steroidogenesis, other structurally related
isoprenoids, such as geraniol (GOH) and farnesol (FOH) that have two and three isoprene
units, respectively, as well as phytol (POH) and geranylgeranyl diphosphate (GGPP), were
also examined (Figure 6). Accordingly, testosterone and progesterone levels were markedly
increased upon treatment with POH and GGPP in I‐10 cells. In contrast, FOH increased the
levels of progesterone but not testosterone, whereas GOH did not affect steroidogenesis in I‐
10 cells [33]. These results indicate that most of the tested isoprenoids, and particularly POH,
can stimulate the steroidogenic pathway in I‐10 cells to the same extent as GGOH.
In summary, the novel role of MK‐4 in stimulating steroidogenesis in I‐10 cells through
regulation of cAMP/PKA signaling may depend on GGOH and other structurally related
isoprenoids. In addition, we found that MK‐4, but not GGOH, enhanced glucose‐stimulated
insulin secretion (GSIS) by altering cAMP levels in INS‐1 insulinoma cells (unpublished data).
Some studies have reported that low testosterone levels could predict the development of type
2 diabetes and cardiovascular disease and have been linked to the increased risk of mortality
in men [26–30]. It remains to be established if there is a direct connection between these diseases
and vitamin K and what the different functions of MK‐4 and GGOH may be. Taken together,
these findings provide novel mechanistic insights in the process of steroidogenesis and GSIS
and may be useful for the development of therapeutic strategies for men.
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